Aims To assess cytokine levels in peripheral blood and tears of patients after allogeneic haematopoietic stem cell ...
The NIH has established the Standardized Organoid Modeling Center, aiming to develop reproducible, human-based models using ...
About five months after the U.S. FDA disclosed its roadmap to move away from animal testing in favor of new approaches for biopharma drug development, the U.S. National Institutes of Health (NIH) said ...
Scientists seeking NIH funding for projects involving overseas partners will encounter a new grant system starting early next ...
Chaos in research funding across universities threatens to derail a generation of promising scientists. The fallout could impact medicine for years.
Autoimmune hepatitis (AIH) is a liver disease of unknown cause characterized by hypergammaglobulinemia, typical or compatible liver histology, the absence of viral hepatitis and the production of ...
The National Institutes of Health’s flagship long COVID initiative, RECOVER—short for Researching COVID to Enhance Recovery—has after a year of deliberation selected several drug candidates to test as ...
A groundbreaking wearable device is set to change how diabetes is managed through personalized, real-time care. Developed by researchers in Israel and China, the microneedle-based system offers a new ...
The findings highlight the importance of environmental and anthropogenic factors in shaping the transmission dynamics of the ...
Among 1,000 US respondents, 54% said they weren't familiar with C difficile infection, down from 60% in a 2021 survey.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback